Nicola Goatman[email protected]MRIMore T, doctor? No thanksAs the European market recovers from economic turmoil, cost is an ever important factor in MRI purchasing decisions, and advanced 1.5-tesla systems are likely to account for a far higher proportion of unit shipments compared with 3-tesla systems over the next five years.March 11, 2015Page 1 of 1Top StoriesAIU.S. FDA may need to clarify SaMD validation standardsIn a video interview, a Dana-Farber Cancer Institute expert describes what the "rigor spectrum" is in validation study designs.Molecular ImagingPSMA-PET/CT may replace NaF-PET/CT in advanced prostate cancerWomens ImagingPreop breast MRI improves surgical planning, but use disparities remainWomens ImagingFIGO classification from MRI leads to moderate agreement among radsSponsor ContentRegister Now: Breaking Barriers in Breast Imaging Webinar